Market OpportunitiesThe recent endorsement by EU member states on the regulation of plants obtained by New Genomic Techniques could eventually translate into an expanded market opportunity for Cibus in Europe.
Regulatory ApprovalCibus' disease resistance traits under development in Canola received an approval from the USDA's Animal and Plant Health Inspection Service, which determined that the gene-editing practices won't face higher regulatory scrutiny.
Revenue GrowthCibus' revenues increased by 135% year-over-year, mainly through collaboration agreements and sales related to developing a palm oil alternative.